Oku Digital Health launches from Topcon to link eye care, primary care - Ophthalmology Times
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Ali Tafreshi discusses Oku Digital Health, launched from Topcon to link eye care with primary care, and the barriers ahead. Topcon Healthcare, Inc. has launched Oku Digital Health, Inc., a separate company that will build the referral and data infrastructure meant to connect eye imaging with primary care, specialty medicine, and pharmaceutical research.¹ Ali Tafreshi, chief executive officer of both companies, told Ophthalmology Times that fragmented care and limited access remain the central problems. He added that regulatory, reimbursement, and data flow barriers have not gone away. According to the company, Oku is headquartered in La Jolla, California, and draws on a network of more than 10,000 connected care locations.¹ It will debut at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting in New Orleans.¹ Tafreshi said Topcon spent several years investing in artificial intelligence (AI), cloud infrastructure, data platforms, and more automated diagnostic devices under its Healthcare from the Eye initiative. Those assets now form Oku.
This article is an excerpt. To read the full content, visit the original source. Ophthalmology Times
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!